Is Meniscus Surgery Worth It? What 10-Year Data Reveals

There is a question that sounds unreasonable until you look at the evidence: what if one of the most commonly performed knee operations in the country worked no better than a fake one?

That is precisely what a landmark 10-year study published in the New England Journal of Medicine found. Patients who received real meniscus surgery did no better than patients who received a placebo procedure. Same incisions, same operating room, same recovery instructions — and the same outcomes, whether or not anything was actually done inside the knee.

The follow-up finding is the one that should change your decision-making. Surgery patients were three times more likely to need a total knee replacement within a decade.

What that combination actually means

Take those two findings together, because separately they are interesting and together they are decisive.

The first says the operation did not deliver a benefit over placebo. The second says it tripled the odds of arriving at a replacement within ten years.

An intervention that does not outperform a sham but does accelerate the path to an irreversible surgery is not a neutral choice. It is not a “might as well try it” option. Doing nothing at all would, on these numbers, have left the knee in better shape.

You are not a meniscus tear. You are not “the right knee” on a schedule. That reduction is exactly how a knee ends up being treated as a part to be trimmed rather than a structure to be kept.

Preservation versus subtraction

Here is the underlying principle, and once you see it you will recognize it across all of orthopedics.

Arthroscopic meniscus surgery is fundamentally subtractive. Damaged tissue is trimmed away. The knee is left with less meniscus than it had before — and the meniscus is the structure that distributes load across the joint surface. Remove some of it and the remaining cartilage absorbs more force per square inch than it was designed for.

Which is a plausible mechanism for why the surgery group reached replacement three times as often. The immediate problem was addressed by removing the thing that was protecting the joint.

Preservation runs the other direction. It keeps the structure and works on making it functional again. The knee you save is the knee you keep.

What a preservation approach looks like

Orthobiologics. PRP and stem cell therapies deliver your body’s own repair signaling into tissue that has stopped repairing itself. The goal is not to trim damaged tissue away but to change whether it can heal.

The data point that matters here is specific: a 90% surgery-free survival rate at five years with precise intrameniscal PRP. Nine in ten patients still had their own meniscus, without an operation, half a decade later.

Note the word intrameniscal. That is not an injection into the general vicinity of the knee. It is placement into the meniscus itself.

Ultrasound-guided precision. Sub-millimeter accuracy, not blind injection. The distinction is not a technicality — an orthobiologic delivered adjacent to a lesion is not the same treatment as one delivered into it, and the outcome data reflects work done with guidance.

Metabolic optimization. Preparing the soil so the body can actually heal. An injection is an instruction, and a body in metabolic disarray cannot execute it. This is why evaluation precedes intervention rather than following it — the terrain determines whether the biology has any capacity to respond.

The system this sits inside

None of this is a criticism of the surgeons performing these procedures. It is a criticism of an assembly-line model of orthopedic care — one that moves patients efficiently from scan to procedure without pausing on the question of whether the finding on the scan is generating the pain, and whether the proposed intervention outperforms doing nothing.

That model is fast and it is well reimbursed. It is not built to ask whether preservation was possible. That question has to be raised somewhere, and usually the only person positioned to raise it is you.

This is not a quick fix. Biological repair is measured in months. What it offers in exchange is durability, and a knee that is not on an accelerated track to arthritis.

Frequently asked questions

Key takeaways

• A landmark 10-year study in the New England Journal of Medicine found meniscus surgery no better than a placebo procedure.
• Patients who had the surgery were three times more likely to need a total knee replacement within a decade.
• Arthroscopic meniscus surgery is subtractive — it removes the structure that distributes load across the joint.
• Precise intrameniscal PRP has shown a 90% surgery-free survival rate at five years.
• Ultrasound guidance and metabolic preparation are what make orthobiologic delivery a targeted intervention rather than a hopeful one.

Medically reviewed by Gurpreet Singh Padda, MD, MBA, MHP — Board Certified in Anesthesiology, Pain Medicine, Interventional Pain Management, Addiction Medicine, and Obesity Medicine. Last reviewed July 2026.

This article is educational and is not a substitute for evaluation, diagnosis, or treatment by a physician. Individual results vary, and not every patient is a candidate for the therapies described. Do not start, stop, or change any treatment without consulting your physician. Orthobiologic therapies including PRP are not FDA-approved for this indication and are provided as part of physician-directed care.